CLINICAL_TRIALS
trial_result
· 2024-08-15
Clinical Trial Update: Relative Bioavailability and Food Effect Study of CVN424 [Phase 1]
Summary
Phase 1 study evaluating the relative bioavailability and food effect of CVN424 in Parkinson's disease; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cerevance Beta, Inc. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-08-15